The 15 analysts offering 12-month price forecasts for Arena Pharmaceuticals Inc have a median target of 100.00, with a high estimate of 120.00 and a low estimate of 80.00. The median estimate represents a +49.88% increase from the last price of 66.72.
The current consensus among 15 polled investment analysts is to Buy stock in Arena Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$2.20
Reporting Date Aug 09
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.